Constitutively active Harvey Ras confers resistance to epidermal growth factor receptor-targeted therapy with Cetuximab and Getifinib Journal Articles Refereed uri icon

Overview

Published in

  • Cancer Letters

Time

Date/time value

  • 2011

Additional Document Info

Parent Title

  • Cancer Letters

Volume

  • 306

Issue

  • 1

Publisher

  • Elsevier Science Ireland